Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 May 25;52(4):1162–1177. doi: 10.4143/crt.2020.138

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 4. — The relationship between fibroblast growth factor receptor 4 (FGFR4) genotype and oxaliplatin (OXA) resistance. (A-D) Effects of different OXA concentrations on the activity of SGC7901 and BGC803 cells. NC, normal control. (E-H) Flow cytometry: apoptosis rate of gastric cancer (GC) cells with different FGFR4 genotypes after OXA addition for 24 hours. (I-L) Fluorescent staining for apoptosis of GC cells with different FGFG4 genotypes (green represents early apoptosis and red represents apoptosis death). PI, propidium iodide. (M, N) Western bolt was used to detect the changes of apoptosis molecules in GC cells with different FGFG4 genotypes before and after OXA addition. ^*p < 0.05.